48 related articles for article (PubMed ID: 14568968)
1. CC chemokine receptor 2 expression in donor cells serves an essential role in graft-versus-host-disease.
Rao AR; Quinones MP; Garavito E; Kalkonde Y; Jimenez F; Gibbons C; Perez J; Melby P; Kuziel W; Reddick RL; Ahuja SK; Ahuja SS
J Immunol; 2003 Nov; 171(9):4875-85. PubMed ID: 14568968
[TBL] [Abstract][Full Text] [Related]
2. IL-17 contributes to CD4-mediated graft-versus-host disease.
Kappel LW; Goldberg GL; King CG; Suh DY; Smith OM; Ligh C; Holland AM; Grubin J; Mark NM; Liu C; Iwakura Y; Heller G; van den Brink MR
Blood; 2009 Jan; 113(4):945-52. PubMed ID: 18931341
[TBL] [Abstract][Full Text] [Related]
3. Curcumin attenuates acute graft-versus-host disease severity via in vivo regulations on Th1, Th17 and regulatory T cells.
Park MJ; Moon SJ; Lee SH; Yang EJ; Min JK; Cho SG; Yang CW; Park SH; Kim HY; Cho ML
PLoS One; 2013; 8(6):e67171. PubMed ID: 23840617
[TBL] [Abstract][Full Text] [Related]
4. Nrf2 regulates CD4
Tsai JJ; Velardi E; Shono Y; Argyropoulos KV; Holland AM; Smith OM; Yim NL; Rao UK; Kreines FM; Lieberman SR; Young LF; Lazrak A; Youssef S; Fu YY; Liu C; Lezcano C; Murphy GF; Na IK; Jenq RR; Hanash AM; Dudakov JA; van den Brink MRM
Blood; 2018 Dec; 132(26):2763-2774. PubMed ID: 30381375
[TBL] [Abstract][Full Text] [Related]
5. CCR1/CCL5 (RANTES) receptor-ligand interactions modulate allogeneic T-cell responses and graft-versus-host disease following stem-cell transplantation.
Choi SW; Hildebrandt GC; Olkiewicz KM; Hanauer DA; Chaudhary MN; Silva IA; Rogers CE; Deurloo DT; Fisher JM; Liu C; Adams D; Chensue SW; Cooke KR
Blood; 2007 Nov; 110(9):3447-55. PubMed ID: 17641205
[TBL] [Abstract][Full Text] [Related]
6. Single-cell transcriptomics of alloreactive CD4+ T cells over time reveals divergent fates during gut graft-versus-host disease.
Engel JA; Lee HJ; Williams CG; Kuns R; Olver S; Lansink LI; Soon MS; Andersen SB; Powell JE; Svensson V; Teichmann SA; Hill GR; Varelias A; Koyama M; Haque A
JCI Insight; 2020 Jul; 5(13):. PubMed ID: 32484791
[TBL] [Abstract][Full Text] [Related]
7. Signaling through the type 2 cannabinoid receptor regulates the severity of acute and chronic graft-versus-host disease.
Yuan CY; Zhou V; Sauber G; Stollenwerk T; Komorowski R; López A; Tolón RM; Romero J; Hillard CJ; Drobyski WR
Blood; 2021 Mar; 137(9):1241-1255. PubMed ID: 33027805
[TBL] [Abstract][Full Text] [Related]
8. Thrombin receptor activating peptide-6 decreases acute graft-versus-host disease through activating GPR15.
Liu C; Lan Q; Cao S; Zheng F; Liang Y; Shen J; Wang Y; Ikezoe T; Xu K; Pan B
Leukemia; 2024 Jun; 38(6):1390-1402. PubMed ID: 38459169
[TBL] [Abstract][Full Text] [Related]
9. Lithothamnion muelleri controls inflammatory responses, target organ injury and lethality associated with graft-versus-host disease in mice.
Rezende BM; Bernardes PT; Resende CB; Arantes RM; Souza DG; Braga FC; Castor MG; Teixeira MM; Pinho V
Mar Drugs; 2013 Jul; 11(7):2595-615. PubMed ID: 23873335
[TBL] [Abstract][Full Text] [Related]
10. IL4RA on lymphatic endothelial cells promotes T cell egress during sclerodermatous graft versus host disease.
Urso K; Alvarez D; Cremasco V; Tsang K; Grauel A; Lafyatis R; von Andrian UH; Ermann J; Aliprantis AO
JCI Insight; 2016 Aug; 1(12):. PubMed ID: 27547823
[TBL] [Abstract][Full Text] [Related]
11. The microbiome-the revealing of a long time unbeknownst factor for outcome in murine models of graft-versus-host disease.
Kumari R; Palaniyandi S; Hildebrandt GC
Bone Marrow Transplant; 2021 Aug; 56(8):1777-1783. PubMed ID: 34052837
[No Abstract] [Full Text] [Related]
12. The role of chemokines in mediating graft versus host disease: opportunities for novel therapeutics.
Castor MG; Pinho V; Teixeira MM
Front Pharmacol; 2012; 3():23. PubMed ID: 22375119
[TBL] [Abstract][Full Text] [Related]
13. CD99-dependent expansion of myeloid-derived suppressor cells and attenuation of graft-versus-host disease.
Park HJ; Byun D; Lee AH; Kim JH; Ban YL; Araki M; Araki K; Yamamura K; Kim I; Park SH; Jung KC
Mol Cells; 2012 Mar; 33(3):259-67. PubMed ID: 22350746
[TBL] [Abstract][Full Text] [Related]
14. CCR2 plays a critical role in dendritic cell maturation: possible role of CCL2 and NF-kappa B.
Jimenez F; Quinones MP; Martinez HG; Estrada CA; Clark K; Garavito E; Ibarra J; Melby PC; Ahuja SS
J Immunol; 2010 May; 184(10):5571-81. PubMed ID: 20404272
[TBL] [Abstract][Full Text] [Related]
15. Graft-versus-leukemia effect of nonmyeloablative stem cell transplantation.
Imamura M; Tanaka J
Korean J Intern Med; 2009 Dec; 24(4):287-98. PubMed ID: 19949725
[TBL] [Abstract][Full Text] [Related]
16. Acute graft-versus-host disease: from the bench to the bedside.
Socié G; Blazar BR
Blood; 2009 Nov; 114(20):4327-36. PubMed ID: 19713461
[TBL] [Abstract][Full Text] [Related]
17. Cardiac troponins and autoimmunity: their role in the pathogenesis of myocarditis and of heart failure.
Kaya Z; Katus HA; Rose NR
Clin Immunol; 2010 Jan; 134(1):80-8. PubMed ID: 19446498
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow deficient in IFN-{gamma} signaling selectively reverses GVHD-associated immunosuppression and enhances a tumor-specific GVT effect.
Capitini CM; Herby S; Milliron M; Anver MR; Mackall CL; Fry TJ
Blood; 2009 May; 113(20):5002-9. PubMed ID: 19258593
[TBL] [Abstract][Full Text] [Related]
19. Identification of cardiac troponin I sequence motifs leading to heart failure by induction of myocardial inflammation and fibrosis.
Kaya Z; Göser S; Buss SJ; Leuschner F; Ottl R; Li J; Völkers M; Zittrich S; Pfitzer G; Rose NR; Katus HA
Circulation; 2008 Nov; 118(20):2063-72. PubMed ID: 18955666
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
